Boceprevir early-access for advanced-fibrosis/cirrhosis in Asia-pacific hepatitis C virus genotype 1 non-responders/relapsers

doi:10.3748/wjg.v21.i28.8660

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7041)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

395

WORD

209

HTML

3035

Figures (1-4)

314

Tables (1-2)

225

Sum=4178

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1257

Download

1606

Sum=2863

Jul 28, 2015 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. Jul 28, 2015; 21(28): 8660-8669
Published online Jul 28, 2015. doi: 10.3748/wjg.v21.i28.8660

Full Size Figure Download Figure

Figure 3 Sustained virological response by IL28B genotype. A: Sustained virological response (SVR) rates by IL28B CC vs non-CC genotypes; B: SVR rates in Asians vs Caucasians by IL28B CC vs non-CC genotype; C: SVR by undetectable hepatitis C virus (HCV) RNA at treatment week 4, 8 and 12 comparing IL28B CC vs non-CC genotype; D: SVR in prior non-responders and relapsers comparing IL28B CC vs non-CC genotypes. Significant differences are shown.

Citation: Sukeepaisarnjaroen W, Pham T, Tanwandee T, Nazareth S, Galhenage S, Mollison L, Totten L, Wigg A, Altus R, Colman A, Morales B, Mason S, Jones T, Leembruggen N, Fragomelli V, Sendall C, Guan R, Sutedja D, Tan SS, Dan YY, Lee YM, Luman W, Teo EK, Than YM, Piratvisuth T, Lim SG. Boceprevir early-access for advanced-fibrosis/cirrhosis in Asia-pacific hepatitis C virus genotype 1 non-responders/relapsers. World J Gastroenterol 2015; 21(28): 8660-8669
URL: https://www.wjgnet.com/1007-9327/full/v21/i28/8660.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i28.8660